Statements Author contributions CC and AP equally contributed to the literature review and in writing the manuscript
Treat Endocrinol 3:173189 Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA, Munzel U, Yakhno N, Raz I, Novosadova M, Maus J, Samigullin R (2006) Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial
Some medical providers prescribe it to support gut health and intestinal repair (BPC-157 is the primary peptide responsible for those effects.) The rest of the stack (TB-500, Thymosin Alpha-1, and GHK-Cu) can enhance or complement BPC-157s gut-healing benefits, but their roles are secondary.
Bitte beachten Sie, dass dabei Daten an Drittanbieter weitergegeben werden.
Can I use GHK-CU with retinol